Mentice AB (FRA:MN2) Stock Price, Trades & News

Mentice AB is a Swedish medical technology company that develops software and hardware simulation systems for image-guided interventional therapies. Its solutions allow healthcare professionals to acquire, retain, and refine procedural skills in a risk-free environment, covering neurovascular, cardiovascular, and peripheral interventions. The company serves two main customer groups through its segments: the Medical Device Industry, which uses its end-to-end simulation platforms to support the development, testing, and launch of interventional therapies, and Healthcare Systems, which deploy the technology for clinical training and proficiency assessment. Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. Revenue is generated primarily from sales and licensing of simulation systems, software, and related services. Mentice operates across EMEA, APAC, and the Americas, serving hospitals, medical device manufacturers, and educational institutions worldwide.

Financial Strength

6/10

Name	Current	Vs Industry
Cash-To-Debt	4.5
Equity-to-Asset	0.41
Debt-to-Equity	0.11
Debt-to-EBITDA	0.47
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	1.83	Distress Grey Safe
Beneish M-Score	-2.57	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

7/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	5.1
	3-Year EBITDA Growth Rate	149.9
	3-Year EPS without NRI Growth Rate	1.5
	3-Year Book Growth Rate	-7.8
	Future 3-5Y Total Revenue Growth Rate Estimate	10.95

Momentum Rank

7/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	85.64
	9-Day RSI	74.53
	14-Day RSI	65.97
	3-1 Month Momentum %	8.93
	6-1 Month Momentum %	-0.41
	12-1 Month Momentum %	14.55

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1
	Quick Ratio	0.89
	Cash Ratio	0.36
	Days Inventory	190.26
	Days Sales Outstanding	89.81
	Days Payable	90.03

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-2.8
	Shareholder Yield %	-0.6

Profitability Rank

4/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	88.37
	Operating Margin %	-0.14
	Net Margin %	-1.52
	EBITDA Margin %	9.53
	FCF Margin %	6.88
	OCF Margin %	8.31
	ROE %	-3.8
	ROA %	-1.58
	ROIC %	-0.15
	3-Year ROIIC %	26.22
	ROC (Joel Greenblatt) %	6.11
	ROCE %	1.2
	Years of Profitability over Past 10-Year	2

GF Value Rank

4/10

	Name	Current	Vs Industry		Vs History
	Forward PE Ratio	56.96
	Price-to-Owner-Earnings	55.28
	PS Ratio	1.37
	PB Ratio	3.33
	Price-to-Tangible-Book	21.83
	Price-to-Free-Cash-Flow	34.04
	Price-to-Operating-Cash-Flow	16.57
	EV-to-EBIT	235.25
	EV-to-Forward-EBIT	20.49
	EV-to-EBITDA	12.74
	EV-to-Forward-EBITDA	8.46
	EV-to-Revenue	1.22
	EV-to-Forward-Revenue	1.06
	EV-to-FCF	26.27
	Price-to-GF-Value	0.68
	Price-to-Projected-FCF	3.64
	Earnings Yield (Greenblatt) %	0.43
	FCF Yield %	3.06

Financials (Next Earnings Date:2026-11-10)

Annual Quarterly TTM

FRA:MN2's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Mentice AB Executives

Details

GF Value™: €1.93

FRA:MN2

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 2 Medium warning signs with MN2. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	27.761
	EPS (TTM) (€)	-0.016
	Beta	2.6197
	3-Year Sharpe Ratio	-0.29
	3-Year Sortino Ratio	-0.45
	Volatility %	70.4
	14-Day RSI	65.97
	14-Day ATR (€)	0.022432
	20-Day SMA (€)	1.2015
	12-1 Month Momentum %	14.55
	52-Week Range (€)	0.8 - 1.42
	Shares Outstanding (Mil)	28.13

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Mentice AB Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Mentice AB Stock Events

Financials Calendars

Event	Date	Price (€)
Fourth quarter earnings conference call for 2026	2027-02-26 10:00	In 158 days
Fourth quarter earnings results for 2026	2027-02-26	In 157 days
Third quarter earnings conference call for 2026	2026-11-10	In 49 days
Third quarter earnings results for 2026	2026-11-10	In 49 days
Second quarter earnings conference call for 2026	2026-07-23 10:00	1.15 (+0.00%)
Second quarter earnings results for 2026	2026-07-23	1.15 (+0.00%)
General meeting for 2026	2026-05-26 13:00	1.41 (+0.00%)
First quarter earnings conference call for 2026	2026-05-07	1.17 (+0.00%)
First quarter earnings results for 2026	2026-05-07	1.17 (+0.00%)
Annual report for 2025	2026-04-23	1.18 (+0.00%)

Show

Entries

Mentice AB Frequently Asked Questions

What is Mentice AB(FRA:MN2)'s stock price today?

The current price of FRA:MN2 is €1.31. The 52 week high of FRA:MN2 is €1.42 and 52 week low is €0.80.

When is next earnings date of Mentice AB(FRA:MN2)?

The next earnings date of Mentice AB(FRA:MN2) is 2026-11-10.

Does Mentice AB(FRA:MN2) pay dividends? If so, how much?

Mentice AB(FRA:MN2) does not pay dividend.

Press Release

	Subject	Date
	Mentice AB (publ) receives an order of USD 540,000 for simulation solutions from Corewell Health, Grand Rapids, Michigan, USA	2022-12-30
	Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on October 26 at 10:00 CEST	2022-10-19
	Mentice AB (STO: MNTC) completes the acquisition of ANKYRAS	2022-07-10
	Mentice AB explores the conditions for carrying out a directed share issue of approximately SEK 60 million	2022-07-09
	Mentice AB acquires all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.	2022-07-09
	Mentice AB completes a directed new share issue of approximately SEK 60 million which was significantly oversubscribed	2022-07-09
	Mentice receives an initial order of USD 1.93million for simulation solutions and development services from Medtronic	2022-07-09
	Mentice AB (STO: MNTC) completes the acquisition of ANKYRAS	2022-06-30
	Mentice AB explores the conditions for carrying out a directed share issue of approximately SEK 60 million	2022-06-29
	Mentice AB acquires all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.	2022-06-29

10/Page

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by FactSet. Analyst estimates data is sourced from both Refinitiv and FactSet, with priority given to Refinitiv data. Data is updated daily.